Apricus Biosciences Enters Into Common Stock Purchase Agreement With … – MarketWatch

Apricus Biosciences Enters Into Common Stock Purchase Agreement With
MarketWatch
Apricus Biosciences, Inc. (NASDAQ:APRI) (the “Company” or “Apricus”), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced it has entered into a common stock purchase agreement with Aspire Capital

and more

…read more

Scroll to Top